Low complication rates are achievable after post-mastectomy breast reconstruction and radiation therapy

Anderson.    IJROBP 2003:57 :S239

Purpose/Objective: Prior studies have shown a high rate of complications among breast cancer patients who undergo breast reconstruction and post-mastectomy radiation therapy (RT). The optimal RT technique and type of reconstruction for RT have not been well established. Some have avoided the use of bolus or radiation altogether for fear of complications. We report the likelihood of complications and cosmetic results among patients who underwent modified radical mastectomy (MRM) followed by reconstruction and RT.

Materials/Methods: From 1987 to 2002, eighty-five patients with breast cancer underwent MRM, breast reconstruction and post-operative RT. Reconstruction consisted of tissue expander placement with or without a subsequent permanent implant (TE/I) in 50 patients, and an autologous transverse rectus abdominis myocutaneous (TRAM) flap in 35 patients. The median age was 45 years (range: 29–70). Seventy patients received RT after their MRM and reconstruction. The median time from reconstruction to RT was 7 months. Fifteen patients received RT before their reconstruction. The median time from RT to reconstruction was 13 months. The dose to the reconstructed breast/chest wall was 50–50.4 Gy. Four patients received a scar boost (median 10 Gy).  Seventy-eight patients (92%) received chemotherapy and 55 (65%) received Tamoxifen. The median follow-up was 28 months. The primary endpoint of this study was the actuarial incidence of complications involving the reconstruction, dated from the time of initiation of RT (in those patients who underwent reconstruction first) or from the time of reconstruction (in those patients who underwent RT first). Major complications were defined as requiring corrective surgery or loss of reconstruction. Minor complications included infection, chest wall fibrosis, fat necrosis or contracture.  Cosmesis was scored as excellent/good or fair/poor at each follow-up.

Results: The actuarial 5-year rate of all complications was 26%. There were no (0%) major complications at 5 years in the TRAM group compared with 5% in the TE/I group (p=0.21). The 5-year rate of minor complications was 39% for the TRAM group versus 14% for the TE/I group (p=0.04). None (0%) of the TRAM complications required any corrective surgery, whereas 2 (33%) of the TE/I complications required implant removal. 100% of the TRAM patients with complications had statistically significant superior cosmetic scores of excellent/good compared to only 17% of the TE/I patients (p=0.003). The type of bolus used had a significant impact on the complication rates, with a rate of 9% with the custom fashioned bolus compared to 24% with standard bolus (p=0.05). The timing of reconstruction and RT had no significant impact on complication rates. No other factors were predictive of an increased risk of complications.

Conclusions: Patients treated with breast reconstruction and RT can experience a very low rate of major complications. We demonstrate no significant difference in the overall rate of major complications between TRAM and TE/I patients. However, when they occur, complications in the TE/I patients are more serious and associated with poorer cosmesis and implant removal. No subsequent corrective surgery and excellent/good cosmesis was seen in all TRAM patients who experienced complications. In addition, bolus can be safely used during post-mastectomy RT with reconstruction, and we advocate the use of a custom wax bolus to lower the risk of complications in these patients. Post-mastectomy RT should be considered in all eligible patients even in the setting of reconstruction.

Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Radiotherapy and immediate two-stage breast reconstruction with a tissue expander and implant: Complications and esthetic results
Tallet, Agnes  IJROBP 2003:57:136

Purpose To report complications, failure rate, and esthetic results in patients undergoing immediate breast reconstruction with a tissue expander and implant, with or without adjuvant treatment. Methods and materials   We reviewed the records of the 77 patients who underwent immediate breast reconstruction with an expander/implant between January 1999 and December 2000. Complications were assessed using the Common Toxicity Criteria, version 2, scale. Esthetic results were assessed by the physician using five criteria.

Results

Of the 77 patients, 55 had received adjuvant radiotherapy. The median follow-up was 25 months. Complications appeared to correlate with radiotherapy (14% for nonirradiated patients; 51% for irradiated patients; p = 0.006) and adjuvant chemotherapy (54% with chemotherapy [CHT] vs. 25% without CHT; p = 0.02). Breast reconstruction failed in 21% of patients (9% of nonirradiated patients and 24% of irradiated patients; Esthetic results were acceptable in 60% of cases.

Discussion

Our retrospective study concerned a heterogeneous population of patients who all opted for immediate breast reconstruction out of personal choice. The expander/implant technique was applied without selection criteria. Bias was therefore possible, and the results must be interpreted with caution.

The overall complication rate was 40%, comparable to the 42.3% rate reported in a series of 52 nonirradiated women who underwent immediate breast reconstruction with an expander The complication rate in the set of patients without RT (14%) is comparable to rates reported by other series . However, as already noted the complication rate was significantly greater in patients who received RT than in those who did not (51% vs. 14%). After RT, tissue expansion can be difficult and painful, with a risk of rib deformation consecutive to skin fibrosis, even in selected patients This may be especially true in patients irradiated before reconstruction. In 1 reported case, the expander created a bony chest wall deformity (documented by CT scan), because the soft tissue did not yield after RT . In our series, 8 of 55 patients had been irradiated before reconstruction because of ipsilateral recurrence. Five of these 8 patients presented with a complication. It was severe in two (pain in one and necrosis leading to expander removal in the other). Although improvements in RT techniques (discontinuation of cobalt use, CT-based dosimetry) may have lessened the risk of complications, and even though our complication rate was no greater in patients irradiated before rather than after reconstruction, before it can be advocated, immediate reconstruction of previously irradiated patients needs additional study to determine selection criteria.

Lymphorrhea/hematoma, capsular contracture, pain, and inflammation occurred more often in the irradiated than in the nonirradiated patients. Present before RT, lymphorrhea was certainly related to surgery. According to the adage that “nature hates an empty space,” the empty space was filled by lymph. The overall complication rate was greater in patients who received adjuvant chemotherapy than in those who did not (54% vs. 25%, p = 0.02), but the effects of chemotherapy could not be dissociated from those of RT, because all except three of our patients who received chemotherapy also received RT. No statistically significant difference was found in the complication rate in irradiated patients according to whether they received adjuvant chemotherapy (53% vs. 47%, respectively; p = 0.92) or between patients who received chemotherapy before or after reconstruction (p = 0.21). Thus, no definitive conclusion can be made on adverse role of chemotherapy on the complication rate after IBR with an expander. No identical finding has been reported in the literature

Contrary to previous reports  tamoxifen treatment did not significantly increase the complication rate. Because tamoxifen was always prescribed to steroid receptor-positive patients 2–3 weeks after RT completion, transforming growth factor-ß secretion, which is induced by both RT and tamoxifen, may have been minimized, so that fibrosis might be of lower importance. No adjuvant treatment was delayed because of immediate breast reconstruction

Our overall reconstruction failure rate was 19%. It was 9% in the nonirradiated group of 22 patients, which agrees with published values (8% in 62 patients and 8% in 115 patients . One study reported a failure rate of 21% in 87 patients , but Grade 4 reconstructions (poor esthetic results) were defined as “failures” in that study. Using these criteria, the authors concluded that, in the absence of RT, failure was more common with use of an expander/implant than with other types of reconstruction.

Our failure rate was greater in the women who received RT (24% vs. 9%, p = 0.2). These results are also in line with published findings (e.g., 37% vs. 8% . A very high failure rate of 60% (6 of 9 patients) found in one study was not much different from the rates obtained with other reconstruction techniques (e.g., use of autologous tissue) followed by RT and was attributed to nonoptimal RT and outdated implants. The higher failure rate in irradiated patients might be reduced by patient selection, because the incidence of capsular contracture is <15%. Adjuvant chemotherapy was related to a higher failure rate, with the reservation that all these patients (except three) also received RT. Most failures were either due to capsular contracture, with or without pain, or skin necrosis. This suggests a possible relationship with RT worsened by a radiosensitization effect and an impairment of the vessel quality  with chemotherapy.

The esthetic results in irradiated women were judged to be good to excellent in 54%, fair in 11%, poor in 11%, and failures in 24%. They may be biased because they reflect the surgeon’s viewpoint. Salvage reconstruction with a musculocutaneous flap was offered in instances of failure or poor results. The expander was removed in 13 irradiated patients, but RT was the cause of failure in only 9 of them (16% failure rate; 9 of 55). Reconstruction should not have been attempted in 2 hesitant women, and 1 case of inflammation and another of infection could have arisen even without RT. The median follow-up was too short, and an evaluation of the esthetic results is necessary at 5 years, because modifications of prosthesis aspect might occur with time. The literature noted no statistically significant difference in patient satisfaction between irradiated and nonirradiated women, even though RT results in a higher Baker class and thus a reduced esthetic score . Patient satisfaction with tissue expansion often surpasses expectations. Autologous reconstruction may give better esthetic results (i.e., more symmetrical breasts), but it is an involved procedure. Tissue expansion before insertion of a silicone breast prosthesis is relatively easy and swift and gives rise to no extraneous scars or loss of muscle function. The prosthesis, however, has to be replaced every 10 years, and late failures because of infection or exposure may arise A sufficiently long (30 min) preoperative visit is needed to explain the possible complications, the percentage of failure that might be expected, and the possibility of salvage reconstruction by alternative techniques. Moreover, a greater number of reconstructions can be undertaken, because the operation is safer and easier than reconstruction with a musculocutaneous flap. The widest choice should be offered to the patient who has to undergo RT

Conclusion

Immediate breast reconstruction with an expander/implant can be considered even for patients requiring adjuvant treatment. However, the complication and failure rates are three times higher after postexpander radiotherapy.

1